>
Switch to:

Biogen Days Inventory

: 232.02 (As of Sep. 2021)
View and export this data going back to 1991. Start your Free Trial

Biogen's Total Inventories for the three months ended in Sep. 2021 was $1,301 Mil. Biogen's Cost of Goods Sold for the three months ended in Sep. 2021 was $512 Mil. Hence, Biogen's Days Inventory for the three months ended in Sep. 2021 was 232.02.

The historical rank and industry rank for Biogen's Days Inventory or its related term are showing as below:

NAS:BIIB' s Days Inventory Range Over the Past 10 Years
Min: 161.85   Med: 230.95   Max: 259.02
Current: 220.89

161.85
259.02

During the past 13 years, Biogen's highest Days Inventory was 259.02. The lowest was 161.85. And the median was 230.95.

NAS:BIIB's Days Inventory is ranked lower than
79% of the 122 Companies
in the Drug Manufacturers industry.

( Industry Median: 131.63 vs. NAS:BIIB: 220.89 )

Biogen's Days Inventory increased from Sep. 2020 (201.19) to Sep. 2021 (232.02). It might indicate that Biogen's sales slowed down.

Total Inventories can be measured by Days Sales of Inventory (DSI).

Inventory Turnover measures how fast the company turns over its inventory within a year. Biogen's Inventory Turnover for the three months ended in Sep. 2021 was 0.39.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Biogen's Inventory-to-Revenue for the three months ended in Sep. 2021 was 0.47.


Biogen Days Inventory Historical Data

The historical data trend for Biogen's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogen Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Days Inventory
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 233.88 213.21 184.14 161.85 189.33

Biogen Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Days Inventory Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 201.19 194.95 213.80 240.84 232.02

Competitive Comparison

For the Drug Manufacturers - General subindustry, Biogen's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Biogen Days Inventory Distribution

For the Drug Manufacturers industry and Healthcare sector, Biogen's Days Inventory distribution charts can be found below:

* The bar in red indicates where Biogen's Days Inventory falls into.



Biogen Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Biogen's Days Inventory for the fiscal year that ended in Dec. 2020 is calculated as

Days Inventory (A: Dec. 2020 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2019 ) + Total Inventories (A: Dec. 2020 )) / count ) / Cost of Goods Sold (A: Dec. 2020 )*Days in Period
=( (804.2 + 1068.6) / 2 ) / 1805.2*365
=936.4 / 1805.2*365
=189.33

Biogen's Days Inventory for the quarter that ended in Sep. 2021 is calculated as:

Days Inventory (Q: Sep. 2021 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Jun. 2021 ) + Total Inventories (Q: Sep. 2021 )) / count ) / Cost of Goods Sold (Q: Sep. 2021 )*Days in Period
=( (1254.8 + 1347.9) / 2 ) / 511.8*365 / 4
=1301.35 / 511.8*365 / 4
=232.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biogen  (NAS:BIIB) Days Inventory Explanation

An increase of Days Inventory may indicate the company's sales slowed.

1. Total Inventories can be measured by Days Sales of Inventory (DSI).

Biogen's Days Sales of Inventory for the three months ended in Sep. 2021 is calculated as

Days Sales of Inventory (DSI)=Total Inventories/Revenue*Days in Period
=1301.35/2778.9*365 / 4
=42.73

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Biogen's Inventory Turnover for the three months ended in Sep. 2021 is calculated as

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Biogen's Inventory to Revenue for the three months ended in Sep. 2021 is calculated as

Inventory-to-Revenue=Total Inventories / Revenue
=1301.35 / 2778.9
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Biogen Days Inventory Related Terms

Thank you for viewing the detailed overview of Biogen's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Biogen Business Description

Biogen logo
Industry
Healthcare » Drug Manufacturers NAICS : 325412 SIC : 2834
Address
225 Binney Street, Cambridge, MA, USA, 02142
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Executives
Mcdonnell Michael R officer: EVP, Chief Financial Officer C/O IQVIA HOLDINGS INC. 83 WOOSTER HEIGHTS ROAD DANBURY CT 06810
Gregory Ginger officer: EVP, Human Resources C/O BIOGEN INC. 225 BINNEY ST. CAMBRIDGE MA 02142
Kramer Robin officer: VP, Chief Accounting Officer 999 VANDERBILT BEACH ROAD 3RD FLOOR NAPLES FL 34109
Sherwin Stephen A director C/O CELL GENESYS, INC. 500 FORBES BLVD. SOUTH SAN FRANCISCO CA 94080
Hawkins William A director MEDTRONIC INC 710 MEDTRONIC PKWY, MS LC310 MINNEAPOLIS MN 55432-5604
Dorsa Caroline director BIOGEN INC. 225 BINNEY ST. CAMBRIDGE MA 02142
Papadopoulos Stelios director 3 SOMERSET DRIVE SOUTH GREAT NECK NY 11020
Pangia Robert W director 3965 FREEDOM CIRCLE SANTA CLARA CA 95054
Leaming Nancy director C/O HOLOGIC INC BEDFORD MA 01730
Rowinsky Eric K director IMCLONE SYSTEMS INCORPORATED 180 VARICK STREET, 6TH FLOOR NEW YORK NY 10014
Denner Alexander J director C/O SARISSA CAPITAL MANAGEMENT LP 660 STEAMBOAT ROAD, 3RD FLOOR GREENWICH CT 06830
Posner Brian S director 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Mulligan Richard director C/O ICAHN CAPITAL LP 767 FIFTH AVENUE, SUITE 4700 NEW YORK NY 10153
Mantas Jesus B director BIOGEN INC. 225 BINNEY STREET CAMBRIDGE MA 02142
Galdes Alphonse officer: EVP Pharmaceutical Oper & Tech BIOGEN INC. 225 BINNEY ST. CAMBRIDGE MA 02142

Biogen Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)